Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP240820.RA-RUWyE2Wrn1UMemiNE_gGWAO4FDb5MEDE6r9ObwAjTM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP240820.RA-RUWyE2Wrn1UMemiNE_gGWAO4FDb5MEDE6r9ObwAjTM130_assertion type Assertion NP240820.RA-RUWyE2Wrn1UMemiNE_gGWAO4FDb5MEDE6r9ObwAjTM130_head.
- NP240820.RA-RUWyE2Wrn1UMemiNE_gGWAO4FDb5MEDE6r9ObwAjTM130_assertion description "[CPX decreased cell growth and viability of malignant leukemia, myeloma, and solid tumor cell lines as well as primary AML patient samples at low-micromolar concentrations that appear pharmacologically achievable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP240820.RA-RUWyE2Wrn1UMemiNE_gGWAO4FDb5MEDE6r9ObwAjTM130_provenance.
- NP240820.RA-RUWyE2Wrn1UMemiNE_gGWAO4FDb5MEDE6r9ObwAjTM130_assertion evidence source_evidence_literature NP240820.RA-RUWyE2Wrn1UMemiNE_gGWAO4FDb5MEDE6r9ObwAjTM130_provenance.
- NP240820.RA-RUWyE2Wrn1UMemiNE_gGWAO4FDb5MEDE6r9ObwAjTM130_assertion SIO_000772 19589922 NP240820.RA-RUWyE2Wrn1UMemiNE_gGWAO4FDb5MEDE6r9ObwAjTM130_provenance.
- NP240820.RA-RUWyE2Wrn1UMemiNE_gGWAO4FDb5MEDE6r9ObwAjTM130_assertion wasDerivedFrom befree-20140225 NP240820.RA-RUWyE2Wrn1UMemiNE_gGWAO4FDb5MEDE6r9ObwAjTM130_provenance.
- NP240820.RA-RUWyE2Wrn1UMemiNE_gGWAO4FDb5MEDE6r9ObwAjTM130_assertion wasGeneratedBy ECO_0000203 NP240820.RA-RUWyE2Wrn1UMemiNE_gGWAO4FDb5MEDE6r9ObwAjTM130_provenance.